WallStreetZenWallStreetZen

How to Buy Intra Cellular Therapies Stock

Intra Cellular Therapies Inc

Intra-Cellular Therapies, Inc. , a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States.

Intra Cellular Therapies stock last closed at $65.88, down 3.07% from the previous day, and has increased 12.23% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.19 percentage points. Intra Cellular Therapies stock is currently +44.79% from its 52-week low of $45.50, and -13.44% from its 52-week high of $76.11.

There are currently 96.81M shares of ITCI outstanding. The market value of ITCI is $6.38B. In the past 24 hours, 586,929 ITCI shares were traded.

How to Buy Intra Cellular Therapies Stock

Not sure how to invest in Intra Cellular Therapies stock? Here's how.
  1. Decide where to buy Intra Cellular Therapies stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Intra Cellular Therapies stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Fund your brokerage account: Choose your payment method and add your info.
  4. Research Intra Cellular Therapies stock: The Intra Cellular Therapies ticker symbol is ITCI. Is Intra Cellular Therapies stock a good investment? Should you buy shares of ITCI? How do ITCI's underlying business fundamentals look? Do top analysts think Intra Cellular Therapies is a good buy? Why has ITCI's stock price moved recently? (Hint: Our stock market research tools can help you figure out if ITCI is a good stock to buy).
  5. Place your ITCI trade: Decide if you will purchase ITCI shares at the current market price or use a limit order to buy ITCI stock at a specific price.
  6. Keep an eye on your ITCI position: Create a watchlist to important updates regarding your position in Intra Cellular Therapies shares.

Step 1: Decide where to buy Intra Cellular Therapies stock

You need an online brokerage account to access the NASDAQ market and buy ITCI shares.

A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

We believe that eToro is the best online stock brokerage. eToro gives you:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to global markets: From Tech to Utilities, New York to Shanghai — you can fill your portfolio with stocks from the world's leading exchanges.
  • Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by signing up for an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've chosen the right brokerage, it's time to fill out some personal details so you are able to invest in ITCI today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to open your new trading account.
  1. Send your application by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you have filled out your info on a good stock buying app, you can securely and quickly fund your account:

Watch the tutorial below to see the process of transferring money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Intra Cellular Therapies stock

After you have selected the best place to buy Intra Cellular Therapies stock, it's crucial to analyze their stock before you invest, so you actually understand the risk as well as the upside.

Overview of key ITCI info

ITCI Price
$65.88
1w %
-3.74%
1y %
12.23%
5y %
422.44%
P/E
-45.12x
P/B
10.78x
P/S
13.6x
PEG
N/A
Revenue
$464.37M
Earnings
-$139.67M
Fore. Rev. Growth
34.55%
Fore. Earn. Growth
N/A
Market Cap
$6.38B
Next Earnings
May 2, 2024
Next Dividend
N/A

ITCI Zen Score

WallStreetZen was designed to help everyday investors perform more in-depth fundamental analysis.

You can see all of the due diligence checks on ITCI's stock page.

Is ITCI stock undervalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ITCI's intrinsic value.

Using relative valuations metrics:

  • ITCI could be overvalued based on its P/B ratio of 10.78x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.05x

You can do more valuation research on ITCI's stock here.

ITCI Financial Health

Pros:

  • ITCI has cash burn of 124468000. It has enough cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the ITCI balance sheet.
  • There are more short-term assets than short-term liabilities on the ITCI balance sheet.
  • ITCI has $499.69M in cash and short term investments. This is sufficient to cover its annual cash burn of $124.47M.
  • ITCI has a low debt to equity ratio of 0.23.

Cons:

  • ITCI profit margin has gone up by 0.72 percentage points in the past year, but the company is still unprofitable.
  • Total ITCI debt is higher than 5 years ago, relative to shareholder equity.

Is it a good time to buy Intra Cellular Therapies stock, according to Wall Street analysts?

Out of 9 Wall Street analysts who track ITCI, the consensus analyst rating on Intra Cellular Therapies is a Strong Buy

Please note that analyst forecasts are not stock recommendations, nor are they investment advice.

Most Recent ITCI Analyst Ratings

Corinne Jenkins, a top 21% analyst from Goldman Sachs maintains ITCI with a hold rating and raises their ITCI price target from $58.00 to $64.00, on Jan 18, 2024.

Joel Beatty, a top 20% analyst from Baird initiates coverage on ITCI with a buy rating and announces their ITCI price target of $83.00, on Jan 3, 2024.

Ashwani Verma, a top 29% analyst from Bank of America maintains ITCI with a strong buy rating and raises their ITCI price target from $74.00 to $82.00, on Jan 2, 2024.

Bank of America's Ashwani Verma raised their price target on Intra Cellular Therapies (NASDAQ: ITCI) by 10.8% from $74 to $82 on 2024/01/02. The analyst maintained their Strong Buy rating on the stock.

Verma told investors that their price target hike on Intra Cellular Therapies was catalyzed "by the one year added to Caplyta's loss of exclusivity runway to account for its longer-dated patents."

Bank of America sees Caplyta as "positioned to continue to deliver growth in bipolar depression indication with multiple 2024 opportunities to expand the drug's label," the analyst added.

Joseph Thome, a bottom 12% analyst from TD Cowen initiates coverage on ITCI with a buy rating and announces their ITCI price target of $75.00, on Dec 11, 2023.

You can dive deeper into what analysts are saying on the Intra Cellular Therapies stock forecast page.

Metrics for Advanced ITCI Traders

SMA10
67.54
SMA20
67.49
SMA50
68.85
SMA100
67.13
SMA200
61.75
MACD
-0.22
MACD Signal
-0.18
MACD Histogram
-0.03
RSI
43.52
Stochastic %K
33.92
Stochastic %D
46.82
StochRSI %K
21.61
StochRSI %D
37.41

How are ITCI Revenues/Earnings doing?

Last year, ITCI revenue was $464.37M. In the last four year, ITCI's revenue has grown by 835.57% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 29.01%.

Learn more about ITCI's earnings and revenue performance here.

What are ITCI insiders up to?

Over the last 12 months, executives and large shareholders at ITCI have sold more shares than they have bought.

Rory B. Riggs, Director of ITCI, was the latest ITCI insider to buy. They bought $17,992.00 worth of ITCI stock on Mar 31, 2024.

Learn more about who owns ITCI stock here.

Can I rely on ITCI as an income stream?

No, Intra Cellular Therapies doesn't provide an income stream by paying out dividends.

ITCI Social Trading Data

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other investors have to say.

Step 5: Place your ITCI trade

You have two primary options:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are usually sufficient.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at a given dollar amount, use a limit order.

Press the Open button and your broker will execute your order.

If you require additional help investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep an eye on your ITCI position

Now that you own some ITCI stock, you'll want to keep up with your new investment.

Put ITCI on a watchlist to get the latest updates about your ITCI stock.

ITCI Feed

How to Buy Stock in Intra Cellular Therapies

To summarize, here are the 6 steps for buying Intra Cellular Therapies stock:

  1. Decide where to buy Intra Cellular Therapies stock
  2. Create a brokerage account
  3. Fund your brokerage account
  4. Research Intra Cellular Therapies stock
  5. Place your ITCI trade
  6. Keep an eye on your ITCI position

If you require a place to buy stocks, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep an eye on your investment in Intra Cellular Therapies, click below.

NASDAQ: ITCI
$65.88-2.09 (-3.07%)
Updated Apr 12, 2024
Open eToro Account
NASDAQ: ITCI
$65.88-2.09 (-3.07%)
Updated Apr 12, 2024
Open eToro Account

FAQ

How much does it cost to buy one Intra Cellular Therapies share?

As of Apr 12, 2024, it costs $65.88 to buy one share of Intra Cellular Therapies stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.152 shares of ITCI.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Intra Cellular Therapies stock?

According to 9 Wall Street analysts who monitor Intra Cellular Therapies, their consensus recommendation is to buy Intra Cellular Therapies stock.

What is the best way to buy Intra Cellular Therapies stock?

One way to place an order for Intra Cellular Therapies stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.